Search results
Can Esketamine Prevent Postpartum Depression?
Medscape· 1 day agoData suggest that a low dose of esketamine immediately after childbirth reduces major depressive episodes in women with prenatal depression.
Joy-Anna reveals she's 'struggling with postpartum depression' in personal video
The US Sun· 7 days agoJOY-ANNA Duggar has gotten honest with her followers in a new video. "I figured I'd just share the...
Biogen sees ‘encouraging’ trends for postpartum depression drug
BioPharma Dive via Yahoo Finance· 3 days agoTherapeutics and approved by the Food and Drug Administration last August, is the only pill...
The Baby Blues vs. Postpartum Depression: Similarities and Differences
Healthline· 3 days agoThe baby blues, or feeling down, tired, and overwhelmed after giving birth, are common. Feeling some...
Is Natural Hormone Replacement Therapy Better?
Verywell Health via Yahoo News· 2 days agoOophorectomy (surgical removal of the ovaries) is characterized by a sudden decrease in estrogen Cancer treatment, which can also be associated with...
Halle Bailey Opens Up About Having "Severe" Postpartum Depression
Marie Claire· 5 days agoBecoming a parent is physically and mentally taxing, and Halle Bailey wants to end the stigma...
These New Pregnancy Rules Could Upend the Workplace
newser· 7 days agoNew law: This legislation treats pregnancy and related conditions as themselves deserving of "reasonable accommodations" and places the burden on...
Sage Therapeutics Inc (SAGE) Q1 2024 Earnings: Mixed Results Amidst Pipeline Progress
GuruFocus.com via Yahoo Finance· 2 days agoFocusing on depression, neurology, and neuropsychiatry, Sage targets the central nervous system's GABA and NMDA receptor systems. Its notable products include ZURZUVAE for ...
Sage Therapeutics (SAGE) Q1 Earnings Miss, Sales Beat Estimates
Zacks via Yahoo Finance· 24 hours agoSage Therapeutics' (SAGE) first-quarter 2024 results are mixed as earnings miss estimates, but sales...
Mid-Stage Win for Novel Depression Agent; 'Floordrobe' Disorder; CIA Mind Control
MedPage Today· 3 days agoIn the phase II SAVITRI study, once-daily treatment with an investigational, AMPA positive allosteric modulator (NBI-1065845) significantly reduced depression< ...